Safety and Efficacy of a Ginkgo Biloba-Containing Dietary Supplement on Cognitive Function, Quality of Life, and Platelet Function in Healthy, Cognitively Intact Older Adults

Journal of the American Dietetic Association

Volumn 107, Issue 3, 2007, Pages 422-432

  Carlson, Joseph J ^a   Farquhar, John W ^a   DiNucci, Ellen ^a   Ausserer, Laurie ^a   Zehnder, James ^a   Miller, Donald ^a   Berra, Kathy ^a   Hagerty, Lisa ^a   Haskell, William L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLANT EXTRACT;

AGED; ARTICLE; CHEMISTRY; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GINKGO BILOBA; HUMAN; MALE; PHYSIOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAFETY; THROMBOCYTE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; COGNITION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GINKGO BILOBA; HUMANS; MALE; PLANT EXTRACTS; QUALITY OF LIFE; SAFETY; TREATMENT OUTCOME;

CENTELLA ASIATICA; GINKGO BILOBA;

EID: 33847169350     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2006.12.011     Document Type: Article

References (82)

1. Physicians Desk Reference (PDR) for Herbal Medicines (2001), Medical Economics Co, Montvale, NJ
2. Dietary Supplement Health and Education Act of 1994. Washington, DC: Congress Session 103, Pub L No.103.417.
3. Brevoort P. The booming US botanical market-A new overview. Herbalgram 44 (1998) 33-46
4. Blumenthal M., and German Federal Institute for Drugs and Medical Devices. Commission E. The complete German Commission E monographs therapeutic guide to herbal medicines (1998), American Botanical Council, Austin, Tex 11-12
5. Major R.T. The ginkgo, the most ancient living tree. Science 15 (1967) 1270-1273
6. Chavez M.L., and Chavez P.I. Ginkgo (part 1): History, use, and pharmocologic properties. Monographs on alternative therapies. Hosp Pharm 33 (1998) 658-672
7. Jacobs B.P., and Browner W.S. Ginkgo biloba: A living fossil. Am J Med 108 (2000) 341-342
8. Oken B.S., Storzbach D.M., and Kaye J.A. The efficacy of ginkgo biloba on cognitive function in Alzheimer's disease. Arch Neurol 55 (1998) 1409-1415
9. Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schatzberg A.F., and North American EGb Study Group. A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA 278 (1997) 1327-1332
10. Kanowski S., Herrmann W.M., Stephan K., Wierich W., and Horr R. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29 (1996) 47-56
11. Kleijnen J., and Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 34 (1992) 352-358
12. Rai G.S., Shovlin C., and Wesnes K.A. A double-blind, placebo controlled study of ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment. Curr Med Res Opin 12 (1991) 350-355
13. Hofferberth B. The effect of ginkgo biloba extract on neurophysiological and psychometric measurement results in patients with psychotic organic brain syndrome. A double-blind study against placebo. Arzneimittelforschung 39 (1989) 918-922
14. Ritchie K., and Kildea D. Is senile dementia "age related" or "aging related"?. Evidence from a meta-analysis of dementia prevalence in the oldest old. Lancet 346 (1995) 931-934
15. Bundes Anzeiger (Federal Register of Germany) 133 (1994), Bundesanzeiger Verlag, Bonn, Germany 414
16. DeKosky S.T., Fitzpatrick A., Ives D.G., Saxton J., Williamson J., Lopez O.L., Burke G., Fried L., Kuller L.H., Robbins J., Tracy R., Woolard N., Dunn L., Kronmal R., Nahin R., and Furberg C. The Ginkgo Evaluation of Memory (GEM) study. Design and baseline data of a randomized trial of ginkgo biloba extract in prevention of dementia. Contemp Clin Trials 27 (2006) 238-253 [Epub April 19, 2006.]
17. Cieza A., Maier P., and Poppel E. Effects of ginkgo biloba on mental functioning in healthy volunteers. Arch Med Res 34 (2003) 373-381
18. Mix J.A., and Crews Jr. W.D. An examination of the efficacy of ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults. J Altern Complement Med 6 (2000) 219-229
19. Mix J.A., and Crews Jr. W.D. A double-blind, placebo-controlled, randomized trial of ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol 17 (2002) 267-277
20. Santos R.F., Galduroz J.C., Barbieri A., Castiglioni M.L., Ytaya L.Y., and Bueno O.F. Cognitive performance, SPECT, and blood viscosity in elderly non-demented people using Ginkgo biloba. Pharmacopsychiatry 36 (2003) 127-133
21. Wesnes K.A., Ward T., McGinty A., and Petrini O. The memory enhancing effects of a ginkgo biloba/panax ginseng combination in healthy middle-aged volunteers. Psychopharmacol. (Berl) 152 (2000) 353-361
22. Kennedy D.O., Scholey A.B., and Wesnes K.A. Modulation of cognition and mood following administration of single doses of ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiol Behav 75 (2002) 739-751
23. Nathan P.J., Ricketts E., Wesnes K., Mrazek L., Greville W., and Stough C. The acute nootropic effects of ginkgo biloba in healthy older human subjects: a preliminary investigation. Hum Psychopharmacol 17 (2002) 45-49
24. Solomon P.R., Adams F., Silver A., Zimmer J., and DeVeaux R. Ginkgo biloba for memory enhancement; a randomized controlled trial. JAMA 288 (2002) 835-840
25. Burns N.R., Bryan J., and Nettelbeck T. Ginkgo biloba: No robust effect on cognitive abilities or mood in healthy young or older adults. Hum Psychopharmacol 21 1 (2006) 27-37
26. Persson J., Bringlov E., Nilsson L.G., and Nyberg L. The memory-enhancing effects of ginseng and ginkgo biloba in healthy volunteers. Psychopharmacol (Berl) 172 (2004) 430-434 Epub 2003, Nov 25
27. Nathan P.J., Tanner S., Lloyd J., Harrison B., Curran L., Oliver C., and Stough C. Effects of a combined extract of ginkgo biloba and bacopa monniera on cognitive function in healthy humans. Hum Psychopharmacol 19 (2004) 91-96
28. DeFeudis F.V. Ginkgo biloba extract (EGb 761) Pharmacological Activities and Clinical Applications (1991), Elsevier, Paris, France
29. Pietri S., Maurelli E., Drieu K., and Culcasi M. Cardioprotective and anti-oxidant effects of the terpenoid constituents of ginkgo biloba extract (EGb 761). J Mol Cell Cardiol 29 (1997) 733-742
30. Ferrandini C., Sekaki A., and Droy-Lefaix M.T. Oxygen-centered free radicals and their interactions with Egb 761 or CP 202. In: Ferradini C., Droy-Lefaix M.T., and Christen Y. (Eds). Advances in Ginkgo Biloba Extract Research, Vol. 2. Ginkgo Biloba Extract (EGb 761) as a Free Radical Scavenger (1993), Elsevier, Paris, France
31. Kudolo G.B., Dorsey S., and Blodgett J. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. Thromb Res 108 (2002) 151-160
32. Diamond B.J., Shiflett S.C., Feiwel N., Matheis R.J., Noskin O., Richard J.A., and Schoenberger N.E. Ginkgo biloba extract: Mechanisms and clinical indications. Arch Phys Med Rehabil 81 (2000) 668-678
33. Braquet P., and Koltai M. Vasculoprotective effect of the platelet-activating factor antagonist ginkgolide B isolated from ginkgo biloba leaves. In: Clostre F., and De Feudis F.V. (Eds). Advances in Ginkgo Biloba Extract Research, Vol 3. Cardiovascular Effect of Ginkgo Biloba Extract (EGb 761) (1994), Elsevier, Paris, France
34. Chung K.F., McCuster M., Page C.P., Dent G., Guinot P.H., and Barnes P.J. Effect of a ginkolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet 31 (1987) 248-251
35. White H.L., Scates P.W., and Cooper B.R. Extracts of ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 58 (1996) 1315-1321
36. Ramassamy C., Christen Y., Clostre F., and Costentin J. The ginkgo biloba extract EGb 761, increases synaptosomal uptake of 5-hydroxy tryptamine: In vitro and ex vivo studies. J Pharm Pharmacol 44 (1992) 943-945
37. Fetrow C.W., and Avila J.R. Professional's Handbook of Complementary and Alternative Medicines (1999), Springhouse Corp, Springhouse, PA
38. Okada M. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats. Neuroscience 71 (1996) 17-25
39. Peet M., Murphy B., Shay J., and Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43 (1998) 315-319
40. Cesarone M.R., Laurora G., De Sanctis M.T., and Belcaro G. Activity of Centella asiatica in venous insufficiency. Minerva Cardioangiol 40 (1992) 137-143
41. Belcaro G.V., Grimaldi R., and Guidi G. Improvement of capillary permeability in patients with venous hypertension after treatment with TTFCA. Angiology 41 (1990) 533-540
42. Belcaro G.V., Rulo A., and Grimaldi R. Capillary filtration and ankle edema in patients with venous hypertension treated with TTFCA. Angiology 41 (1990) 12-18
43. Cesarone M.R., Laurora G., De Sanctis M.T., Incandela L., Grimaldi R., Marelli C., and Belcaro G. The microcirculatory activity of centella asiatica in venous insufficiency. A double-blind study. Minerva Cardioangiol 42 (1994) 299-304
44. Pointel J.P., Boccalon H., Cloarec M., Ledevehat C., and Joubert M. Titrated extract of Centella asiatica (TECA) in the treatment of venous insufficiency of the lower limbs. Angiology 38 (1987) 46-50
45. Bradwejn J., Zhou Y., Koszycki D., and Shlik J. A double-blind, placebo-controlled study on the effects of gotu kola (Centella asiatica) on acoustic startle response in healthy subjects. J Clin Psychopharmacol 20 (2000) 680-684
46. Corrigan F.M., Van Rhijn A.G., Ijomah G., McIntyre F., Skinner E.R., and Horrobin D.F. Tin and fatty acids in dementia. Prostaglandins Leukot Essent Fatty Acids 43 (1991) 229-238
47. Adams P.B., Lawson S., Sanigorski A., and Sinclair A.J. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31 (1996) S157-S161
48. Nelson G.J., Schmidt P.S., Bartolini G.L., Kelley D.S., and Kyle D. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 32 (1997) 1129-1136
49. Chung K.F., McCuster M., Page C.P., Dent G., Guinot P.H., and Barnes P.J. Effect of a ginkolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet 31 (1987) 248-251
50. Rowin J., and Lewis S.L. Spontaneous bilateral subdural hematomas associated with chronic ginkgo biloba ingestion (see comments). Neurology 46 (1996) 1775-1776
51. Rosenblatt M., and Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract (letter). N Engl J Med 336 (1997) 1108
52. Vale S. Subarachanoid haemorrhage associated with ginkgo biloba. Lancet 352 (1998) 36
53. Benjamin J., Muir T., Briggs K., and Pentland B. A case of cerebral haemorrhage-can ginkgo biloba be implicated?. Postgrad Med J 77 (2001) 112-113
54. Ang-Lee M.K., Moss J., and Yuan C.S. Herbal medicines and perioperative care. JAMA 286 (2001) 208-216
55. Fessenden J.M., Wittenborn W., and Clarke L. Ginkgo biloba: A case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg 67 (2001) 33-35
56. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
57. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., and Adey M.B. Development and validation of a geriatric depression rating scale: A preliminary report. J Psychiatr Res 17 (1983) 37-49
58. Yesavage J.A. The use of self-rating depression scales in the elderly. In: Poon L.W. (Ed). Handbook for Clinical Memory Assessment of Older Adults (1987), American Psychological Association, Washington, DC
59. Stough C., Clarke J., Lloyd J., and Nathan P.J. Neuropsychological changes after 30-day ginkgo biloba administration in healthy participants. Int J Neuropsychopharmacol 4 (2001) 131-134
60. Kennedy D.O., Scholey A.B., and Wesnes K.A. The dose-dependent cognitive effects of acute administration of ginkgo biloba to healthy young volunteers. Psychopharmacology 151 (2000) 416-423
61. Subhan Z., and Hindmarch I. The psychopharmacological effects of ginkgo biloba extract in normal healthy volunteers. Int J Clin Pharmacol Res 4 (1984) 89-93
62. Block G., Hartman A.M., Dresser C.M., Carroll M.D., Gannon J., and Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124 (1986) 453-469
63. Benton A.L., Varney N.R., and Hamsher K. Visuospatial judgement: A clinical test. Arch Neurol 35 (1978) 364-367
64. Benton A.L., and Hamsher K. Multilingual Aphasia Examination (1978), University of Iowa Hospitals, Iowa City, IA
65. Teng E.L., and Chui H.C. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48 (1987) 314-318
66. Yesavage J.A., Sheikh J.I., Tanke E.D., and Hill R.D. Response to memory training and individual differences in verbal intelligence and state anxiety. Am J Psychiatry 145 (1988) 636-639
67. Smith A. The symbol digit modalities test: A neuropsychological test for economic screening of learning and other cerebral disorders. Learning Disorders 3 (1968) 83-91
68. McHorney C.A., Ware Jr. J.E., Lu J.F., and Shelbourne C.D. The MOS 36-item short form health survey 92(SF-36), III: Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32 (1994) 40-66
69. Ware J.E., and Sherbourne C.D. The MOS 36-item short form health survey 92(SF-36) I: Conceptual framework and item selection. Med Care 30 (1992) 473-483
70. Stewart A.L., Hayes R.D., and Ware J.E. The MOS short-form general health survey: Reliability and validity in a patient population. Med Care 26 (1988) 724-735
71. Mammen E.F., Alshameeri R.S., and Comp P.C. Preliminary data from a field trial of the PFA-100 system. Semin Thromb Hemost 21 (1995) 113-121
72. Mammen E.F., Comp P.C., Gosselin R., Greenberg C., Hoots W.K., and Kessler C.M. PFA-100 system: A new method for assessment of platelet dysfunction. Semin Thromb Hemost 24 (1998) 195-202
73. Bal dit Sollier C., Caplain H., and Drouet L. No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haematol 25 (2003) 251-253
74. Elsabagh S., Hartley D.E., Ali O., Williamson E.M., and File S.E. Differential cognitive effects of ginkgo biloba after acute and chronic treatment in healthy young volunteers. Psychopharmacol (Berl) 179 (2005) 437-446 Epub March 2005
75. Chandra R.K. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition 17 (2001) 709-712
76. Smith A., Clark R., Nutt D., Haller J., Hayward S., and Perry K. Anti-oxidant vitamins and mental performance of the elderly. Hum Psychopharmacol Clin Exp 14 (1999) 459-471
77. Gonzales-Gross M., Marcos A., and Pietrzik. Nutrition and cognitive function in the elderly. Br J Nutr 86 (2001) 313-321
78. La Rue A., Koehler K.M., Wayne S.J., Chiulli S.J., Haaland K.Y., and Garry P.J. Nutritional status and cognitive functioning in a normally aging sample: A 6-y reassessment. Am J Clin Nutr 65 (1997) 20-29
79. Miller J.W., Green R., and Ramos M.I. Homocysteine and cognitive function in the Sacramento Area. Latino Study on Aging. Am J Clin Nutr 78 (2003) 441-447
80. Riggs K.M., Spiro A., Tucker K., and Rush D. Relations of vitamin B12, vitamin B6, folate and homocysteine to cognitive performance in the normative aging study. Am J Clin Nutr 63 (1996) 306-314
81. Tucker D.M., Penland J.G., Sandstead H.H., Milne D.B., Heck D.G., and Klevay L.M. Nutrition status and brain function in aging. Am J Clin Nutr 52 (1990) 93-102
82. Braquet P., and Hosford D. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J Ethnopharmacol 32 (1991) 135-139